DNA damage in round spermatids of mice with a targeted disruption of the Pp1c gamma gene and in testicular biopsies of patients with non-obstructive azoospermia
A. Jurisicova et al., DNA damage in round spermatids of mice with a targeted disruption of the Pp1c gamma gene and in testicular biopsies of patients with non-obstructive azoospermia, MOL HUM REP, 5(4), 1999, pp. 323-330
Non-obstructive azoospermia accounts for a considerable proportion of male
factor infertility. Current therapies for treatment of this kind of inferti
lity include procedures such as intracytoplasmic sperm injection (ICSI), ro
und spermatid injection (ROSI), round spermatid nucleus injection (ROSNI) a
nd elongated spermatid injection (ELSI). All involve injection of haploid g
erm cells retrieved from testicular biopsies into recipient oocytes. We hav
e investigated a mouse model of azoospermia for quality of haploid germ cel
l genomes, based on 4,6-diamidino-2-phenylindole (DAPI)/TdT-mediated dUTP n
ick-end labelling (TUNEL) labelling. The mouse model, a targeted mutation i
n the protein phosphatase Icg gene, results in severe depletion of haploid
germ cells from the round spermatid stage on. Mice homozygous for the mutat
ion are completely infertile, and produce only the occasional spermatozoon.
Spermatozoa and round spermatids retrieved from either the epididymides or
the testes of mutant mice displayed very high rates of DNA fragmentation.
In contrast, similar cells retrieved from heterozygous or wild-type litterm
ates displayed low levers of DNA fragmentation. In some cases, the high rat
es of DNA fragmentation in mutant cells could be lowered by inclusion of an
tioxidants in the retrieval media. High rates of DNA fragmentation were als
o observed in round spermatids retrieved from testicular biospies of human
patients with non-obstructive azoospermia. These results suggest that one o
f the features of the pathology associated with azoospermia is fragmented D
NA in haploid germ cells. This raises questions about the suitability of us
ing these cells for fertility treatment.